Résultats: 14

    Guideline No. 450: care of pregnant women living with HIV and interventions to reduce perinatal transmission

    J. obstet. gynaecol. Can; 46 (6), 2024
    This guideline provides an update on the care of pregnant women living with HIV and the prevention of perinatal HIV transmission. This guideline is a revision of the previous guideline, No. 310 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission, a...

    Consolidated guidelines on differentiated HIV testing services

    hese guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to WHO guidelines on HTS, with a focus on new evidence, new recommendations, good practices and operational considerations that respond to the changing needs of...

    Guidelines on long-acting injectable cabotegravir for HIV prevention

    In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing...

    Reducing sexually transmitted infections

    This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B....

    Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

    These guidelines provide guidance on the diagnosis of HIV infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 201...

    Síndrome de la inmunodeficiencia adquirida VIH/SIDA pediátrico

    Generar recomendaciones basadas en la mejor evidencia disponible acerca de la prevención y tratamiento de la infección por VIH en niños expuestos al VIH y niños con VIH/SIDA. Entregar recomendaciones para el manejo y prevención de la infección por VIH en recién nacidos hijos de madres VIH (+). Ent...

    HIV-infektsiooni kokkupuute-eelne ja -järgne profülaktika ning HIV-positiivsete isikute ravi

    HIV is a chronic viral infection that damages the immune system. HIV can be contracted during sexual intercourse or through direct contact with the blood of an infected person (including sharing syringes). The virus can also be transmitted from mother to child during pregnancy, childbirth or breastfeedin...

    Guidelines on the public health response to pretreatment HIV drug resistance

    This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first...

    Guía de práctica clínica síndrome de la inmunodeficiencia adquirida VIH/SIDA

    Generar recomendaciones basadas en la mejor evidencia disponible acerca de la prevención y tratamiento de la infección por VIH y del síndrome de inmunodeficiencia adquirida VIH/SIDA...

    Guía de práctica clínica basada en la evidencia científica para la atención de la infección por VIH en niñas y niños menores de 13 años. Guía para profesionales de la salud

    La presente guía hace recomendaciones para el diagnóstico, la valoración inicial, el manejo y el seguimiento de personas con 13 años de edad o más (incluidas gestantes), con infección por VIH/ Sida, en diferentes niveles de atención nacional. La guía de práctica clínica para manejo de pacientes...